Cook Medical Incorporated
750 Daniels Way
About Cook Medical Incorporated
Since 1963 Cook Medical has worked closely with physicians to develop technologies that eliminate the need for open surgery. Today we are combining medical devices, biologic materials and cellular therapies to help the world’s healthcare systems deliver better outcomes more efficiently. We have always remained family owned so that we have the freedom to focus on what we care about: patients, our employees and our communities.
FOLLOW COOK MEDICAL:
Tweets by Cook Medical
369 articles with Cook Medical Incorporated
At this year’s Vascular Interventional Advances conference, Dr. Michael D. Dake presented data on Zilver® PTX® that supports the device’s benefits across different patient groups..
CORRECTING and REPLACING Cook Medical and Quanta System Announce Distribution Agreement for Laser Systems
Cook Medical and Quanta System have entered into an agreement in which Cook will distribute in some territories a comprehensive offering of Quanta’s holmium and thulium laser systems, laser fibers and accessories.
Cook Medical and Quanta System have entered into an agreement in which Cook will distribute a comprehensive offering of Quanta’s holmium and thulium laser systems, laser fibers and accessories.
Cook Medical is proud to announce that Dave Reed, vice president of Healthcare Solutions, received the Chuck Lauer Award at the Integrated Delivery Network (IDN) Summit on September 10.
"We are honored to receive this award in addition to the Forbes rankings as one of America’s Best Employers for both 2018 and 2019."
8/30/2019Biopharma companies strengthen their leadership and boards with these appointments.
Kelly-Falls and her team members are responsible for standardizing, coordinating, and providing guidance for managing Cook’s suppliers, supplier agreements, and supply chain for Cook Medical globally.
Cook Medical and Zelegent, Inc. Introduce Elevo® Snoring Intervention Set at International Sleep Conference
Cook Medical and Zelegent, Inc., are now training physicians throughout the U.S. on the Elevo® Snoring Intervention Set after it received FDA 510(k) clearance in January.
Cook Medical was honored as one of Bloomington’s Best Places to Work by Bloomington Economic Development Corporation, The Mill and The Herald-Times.
Cook Medical and Ambu A/S have agreed on terms to enter into a partnership under which Cook will distribute Ambu’s single-use, disposable duodenoscope in the U.S., following FDA clearance.
Cook provides this data to encourage further collaboration with researchers to benefit patients with peripheral arterial disease.
Forbes announced that Cook Medical has ranked 48 of 500 large companies in the America’s Best Employers of 2019 listing.
First US Patient Treated with Cook Medical’s Recently Approved Zenith® Dissection Endovascular System
Following the recent FDA approval of Cook Medical’s Zenith Dissection Endovascular System, Cooper University Health Care in Camden, New Jersey, has treated the first patient in the US with the device as part of Cook’s US commercial launch.
VIVA Physicians Selects NAMSA as Statistical Analytic Group to Evaluate the Safety of Paclitaxel Drug-Eluting Technologies in PAD
VIVA Physicians announced the selection of NAMSA as the independent statistical analysis group to examine individual patient-level data associated with paclitaxel-coated balloons and stent trials used in the treatment of peripheral artery disease in the superficial femoral artery.
Mauna Kea Technologies Provides an Update on Its Commercial Partnership Agreement for Urological Applications
Mauna Kea Technologies inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy platform, announced a mutual decision to terminate the development and distribution agreements with Cook Medical.
Jury rejects request for tens of millions of dollars and punitive damages
Findings contradict meta-analysis linking paclitaxel-coated devices and increased mortality
Shore Capital-Backed IZI Medical Products Announces Acquisition of Quick-Core® Biopsy and Breast Localization Needle Assets from Cook Medical
IZI Medical Products, LLC is pleased to announce it has acquired select soft tissue biopsy and breast localization needle assets from Cook Medical (“Cook”).
The agreement was completed on December 27, 2018. Cook will begin converting a portion of the R.J. Reynolds building in Whitaker Park into a world-class medical device manufacturing facility this year.
Cook Medical announced today the availability of the Flourish™ Pediatric Esophageal Atresia device in the U.S.